---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-006661"
form_type: "8-K"
ticker: "DTIL"
cik: "0001357874"
company_name: "PRECISION BIOSCIENCES INC"
filed_at: "2024-01-23T23:59:59+00:00"
generated_at: "2026-06-06T19:55:55.925300+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Precision BioSciences enters new exec employment agreements with enhanced severance

## Summary
- CEO Michael Amoroso: 18-month salary severance, 1.5x target bonus, 25-month equity acceleration.
- CFO Alex Kelly, GC Dario Scimeca, CRO Jeff Smith: 12-month salary severance, 1x target bonus, 13-month equity acceleration.
- Enhanced COBRA premium reimbursement and extended option exercise periods for all four executives.
- Agreements effective Jan 22, 2024, supersede prior employment agreements from September 2021.

## SEC filing metadata
- accession: 0000950170-24-006661
- form_type: 8-K
- ticker: DTIL
- cik: 0001357874
- company_name: PRECISION BIOSCIENCES INC
- filed_at: 2024-01-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357874/000095017024006661/0000950170-24-006661-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357874/000095017024006661/dtil-20240122.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-006661
- JSON: https://secwatch.observer/filing/0000950170-24-006661.json
- Plain text: https://secwatch.observer/filing/0000950170-24-006661.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.